BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong XC, Chowdhury K, Huang M, Kim HG. Signal Transduction and Molecular Regulation in Fatty Liver Disease. Antioxid Redox Signal 2021. [PMID: 33906425 DOI: 10.1089/ars.2021.0076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lv T, Zhang C, Hu L, Wang C, Li S, Wang H, Qi W. Berberine in Sepsis: Effects, Mechanisms, and Therapeutic Strategies. Journal of Immunology Research 2023;2023:1-8. [DOI: 10.1155/2023/4452414] [Reference Citation Analysis]
2 Chowdhury K, Huang M, Kim HG, Dong XC. Sirtuin 6 protects against hepatic fibrogenesis by suppressing the YAP and TAZ function. FASEB J 2022;36:e22529. [PMID: 36036554 DOI: 10.1096/fj.202200522R] [Reference Citation Analysis]
3 Li H, Liu NN, Li JR, Dong B, Wang MX, Tan JL, Wang XK, Jiang J, Lei L, Li HY, Sun H, Jiang JD, Peng ZG. Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease. Front Pharmacol 2022;13:843872. [PMID: 35250593 DOI: 10.3389/fphar.2022.843872] [Reference Citation Analysis]
4 Contreras L, Rodríguez-gil A, Muntané J, de la Cruz J. Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells. Cancers 2022;14:1204. [DOI: 10.3390/cancers14051204] [Reference Citation Analysis]
5 Kim HG, Cho JH, Kim J, Kim SJ. The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis. Front Physiol 2021;12:691738. [PMID: 34335299 DOI: 10.3389/fphys.2021.691738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]